ACADIA PHARMACEUTICALS INC — Director's Dealing 2012

Jun 11, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ACADIA PHARMACEUTICALS INC (ACAD)
CIK: 0001070494
Period of Report: 2012-06-08

Reporting Person: KAPLAN LESTER J PH D (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-06-08	Stock option (right to buy)	$1.36	A	10000	Acquired	2022-06-07	Common stock (10000)	Direct
2012-06-08	Stock option (right to buy)	$1.36	A	55147	Acquired	2022-06-07	Common stock (55147)	Direct

Footnotes

F1: 25% of the shares subject to the Stock Option vest and become exercisable at the end of each 3-month period following the date of grant.

F2: The Reporting Person has elected to convert annual retainer fees of $25,000 into a stock option under the terms of the Issuer's Outside Director Compensation Program.